Shoreline Biosciences

Shoreline Biosciences

Developing clinically effective immunotherapies using intelligently engineered iPSC-derived allogeneic cells. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€509—764m (Dealroom.co estimates Nov 2021.)
San Diego California (HQ)
Authorizing premium user...